125 related articles for article (PubMed ID: 38580157)
1. Re: Laboratory safety evaluation of bedinvetmab, a canine anti-nerve growth factor monoclonal antibody, in dogs.
Farrell M; Adams R; von Pfeil DJF
Vet J; 2024 Apr; 305():106104. PubMed ID: 38580157
[TBL] [Abstract][Full Text] [Related]
2. Laboratory safety evaluation of bedinvetmab, a canine anti-nerve growth factor monoclonal antibody, in dogs.
Krautmann M; Walters R; Cole P; Tena J; Bergeron LM; Messamore J; Mwangi D; Rai S; Dominowski P; Saad K; Zhu Y; Guillot M; Chouinard L
Vet J; 2021 Oct; 276():105733. PubMed ID: 34391918
[TBL] [Abstract][Full Text] [Related]
3. A prospective, randomized, double-blind, placebo-controlled multisite, parallel-group field study in dogs with osteoarthritis conducted in the United States of America evaluating bedinvetmab, a canine anti-nerve growth factor monoclonal antibody.
Michels GM; Honsberger NA; Walters RR; Kira S Tena J; Cleaver DM
Vet Anaesth Analg; 2023 Sep; 50(5):446-458. PubMed ID: 37541934
[TBL] [Abstract][Full Text] [Related]
4. A prospective, randomized, blinded, placebo-controlled multisite clinical study of bedinvetmab, a canine monoclonal antibody targeting nerve growth factor, in dogs with osteoarthritis.
Corral MJ; Moyaert H; Fernandes T; Escalada M; Kira S Tena J; Walters RR; Stegemann MR
Vet Anaesth Analg; 2021 Nov; 48(6):943-955. PubMed ID: 34565678
[TBL] [Abstract][Full Text] [Related]
5. Does anti-nerve growth factor monoclonal antibody treatment have the potential to replace nonsteroidal anti-inflammatory drugs and opioids in treating hip or knee osteoarthritis? A systematic review of randomized controlled trials.
Zhao D; Zeng LF; Liang GH; Pan JK; Luo MH; Han YH; Liu J; Yang WY
EFORT Open Rev; 2022 Jul; 7(7):470-480. PubMed ID: 35900204
[TBL] [Abstract][Full Text] [Related]
6. Canine Brief Pain Inventory scores for dogs with osteoarthritis before and after administration of a monoclonal antibody against nerve growth factor.
Webster RP; Anderson GI; Gearing DP
Am J Vet Res; 2014 Jun; 75(6):532-5. PubMed ID: 24866508
[TBL] [Abstract][Full Text] [Related]
7. Laboratory safety evaluation of lokivetmab, a canine anti-interleukin-31 monoclonal antibody, in dogs.
Krautmann M; Walters RR; King VL; Esch K; Mahabir SP; Gonzales A; Dominowski PJ; Sly L; Mwangi D; Foss DL; Rai S; Messamore JE; Gagnon G; Schoell A; Dunham SA; Martinon OM
Vet Immunol Immunopathol; 2023 Apr; 258():110574. PubMed ID: 36842258
[TBL] [Abstract][Full Text] [Related]
8. [New drugs for small animals in 2021].
Emmerich IU
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2022 Jun; 50(3):213-224. PubMed ID: 35790168
[TBL] [Abstract][Full Text] [Related]
9. A fully caninised anti-NGF monoclonal antibody for pain relief in dogs.
Gearing DP; Virtue ER; Gearing RP; Drew AC
BMC Vet Res; 2013 Nov; 9():226. PubMed ID: 24206926
[TBL] [Abstract][Full Text] [Related]
10. Anti-nerve growth factor monoclonal antibody: a prospective new therapy for canine and feline osteoarthritis.
Epstein ME
Vet Rec; 2019 Jan; 184(1):20-22. PubMed ID: 30606856
[No Abstract] [Full Text] [Related]
11. Serological biomarker profiles of rapidly progressive osteoarthritis in tanezumab-treated patients.
Karsdal MA; Verburg KM; West CR; Bay-Jensen AC; Keller DS; Arends RHGP
Osteoarthritis Cartilage; 2019 Mar; 27(3):484-492. PubMed ID: 30576794
[TBL] [Abstract][Full Text] [Related]
12. Analgesic effects of nerve growth factor-directed monoclonal antibody on diabetic neuralgia in an animal model.
Dong X; Li H; Pei M; Tan J; Chen G; Li S; Xie Z; Wang Q; Wang G; Chen YL; Wang C
FEBS Open Bio; 2022 Jul; 12(7):1325-1335. PubMed ID: 35417079
[TBL] [Abstract][Full Text] [Related]
13. Could it be osteoarthritis? How dog owners and veterinary surgeons describe identifying canine osteoarthritis in a general practice setting.
Belshaw Z; Dean R; Asher L
Prev Vet Med; 2020 Dec; 185():105198. PubMed ID: 33227581
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of anti-human leukocyte antigen-DR monoclonal antibody therapy in spontaneous canine lymphoma.
Stein R; Balkman C; Chen S; Rassnick K; McEntee M; Page R; Goldenberg DM
Leuk Lymphoma; 2011 Feb; 52(2):273-84. PubMed ID: 21133722
[TBL] [Abstract][Full Text] [Related]
15. Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats.
Enomoto M; Mantyh PW; Murrell J; Innes JF; Lascelles BDX
Vet Rec; 2019 Jan; 184(1):23. PubMed ID: 30368458
[TBL] [Abstract][Full Text] [Related]
16. Development and pharmacokinetic assessment of a fully canine anti-PD-1 monoclonal antibody for comparative translational research in dogs with spontaneous tumors.
Yoshimoto S; Chester N; Xiong A; Radaelli E; Wang H; Brillantes M; Gulendran G; Glassman P; Siegel DL; Mason NJ
MAbs; 2023; 15(1):2287250. PubMed ID: 38047502
[TBL] [Abstract][Full Text] [Related]
17. Development of a monoclonal antibody for the detection of anti-canine CD20 chimeric antigen receptor expression on canine CD20 chimeric antigen receptor-transduced T cells.
Sakai O; Ogino S; Tsukui T; Igase M; Mizuno T
J Vet Med Sci; 2021 Oct; 83(10):1495-1499. PubMed ID: 34408098
[TBL] [Abstract][Full Text] [Related]
18. Identification of a candidate therapeutic antibody for treatment of canine B-cell lymphoma.
Rue SM; Eckelman BP; Efe JA; Bloink K; Deveraux QL; Lowery D; Nasoff M
Vet Immunol Immunopathol; 2015 Apr; 164(3-4):148-59. PubMed ID: 25764941
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis.
Cardoso JMO; Brito RCF; Mathias FAS; Reis LES; Vieira JFP; Ostolin TLVDP; Andrade HM; Ramos GS; Frézard F; Aguiar-Soares RDO; Roatt BM; Reis AB
Mol Immunol; 2022 Jan; 141():70-78. PubMed ID: 34814056
[TBL] [Abstract][Full Text] [Related]
20. A canine-specific anti-nerve growth factor antibody alleviates pain and improves mobility and function in dogs with degenerative joint disease-associated pain.
Lascelles BD; Knazovicky D; Case B; Freire M; Innes JF; Drew AC; Gearing DP
BMC Vet Res; 2015 Apr; 11():101. PubMed ID: 25926287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
